NEW YORK (GenomeWeb News) – Monogram Biosciences said last week that it expects to report fiscal 2008 revenues of approximately $62 million, an increase of 44 percent over 2007 revenues of $43.2 million.

The South San Francisco, Calif.-based firm said that among the contributors to its revenue increase for the year were sales of $16 million from its Trofile assay, which is used to select HIV patients for CCR5 agonists, such as Pfizer's maraviroc (Selzentry).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.